Navigation Links
Apama Medical, A Shifamed Portfolio Company, Closes $3.2M Series A-1 Financing Round
Date:9/16/2013

CAMPBELL, Calif., Sept. 16, 2013 /PRNewswire/ -- Shifamed LLC, a medical technology incubator, announced today that Apama Medical, Inc., one of its privately held portfolio companies, has raised $3.2M in Series A-1 financing.

Broadview Ventures led the financing round and converted its initial investment to Series A-1 equity. Broadview is a Boston-based investment firm focused on accelerating the development of promising technology in cardiovascular and neurovascular disease through targeted investments in early stage ventures. 

"We are pleased to have the support of Broadview Ventures with its solid track record of successful investments," shared Amr Salahieh, Founder and Chairman of Shifamed. "In addition, we are grateful for the NSF SBIR Grant that helped fund our breakthrough technology. Apama Medical offers significant medical technology advancement to electrophysiology (EP) therapies and highlights Shifamed's commitment to improving medical procedures in large, proven markets."

Apama Medical, focused on the EP market, offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation (AF) ablation, which is expected to reach $2.0B in 2017.

"Broadview has a long history of supporting promising medical technology," said Christopher H. Colecchi, Managing Director of Broadview Ventures. "Apama has developed a unique platform in the AF Ablation market. We are excited about continuing our relationship and optimistic about the long-term prospects."

About Shifamed

Shifamed LLC is a privately held medical technology incubator focused on developing new medical products from concept to commercial release. To learn more about Shifamed, please visit www.shifamed.com.

About Apama Medical

Apama Medical is a privately held medical device company formed by Shifamed LLC, a Silicon Valley based medical device incubator. Apama is focused on the rapidly growing electrophysiology (EP) market in which mapping and ablation are estimated to reach $2.0B in 2017. To learn more about Apama Medical, please visit www.apamamedical.com.

About Broadview Ventures

Broadview's mission is to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investments in and support of early stage ventures. To learn more about Broadview Ventures, please visit http://www.broadviewventures.org.

MEDIA CONTACT:
Katie Arnold
SPRIG Consulting LLC
(408) 805-0520
katie@sprigconsulting.com


'/>"/>
SOURCE Shifamed LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Apama Medical Announces Issuance Of Patent For Low Profile Electrodes For Use On Balloons
2. SurgiCount Medical, Inc. announces new 3-year agreement with Novation
3. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
4. Acutus Medical, Inc. bringt 21 Millionen $ für die Serie-B-Finanzierung auf
5. Acutus Medical, Inc. Raises $21 Million Toward its B-Series Financing
6. Astute Medical, Inc. patrocinerà il simposio informativo presso il meeting sulla nefrologia in terapia intensiva
7. Astute Medical, Inc., veranstaltet Symposium aus anlaß des Critical Care Nephrology Kongress
8. Astute Medical, Inc. va accueillir un symposium éducatif lors dune réunion dédiée à la réanimation néphrologique
9. Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
10. Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference
11. Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):